Define Pharmaceuticals Private Limited

Define Pharmaceuticals Private Limited - trading in Ranpur, Odisha, India. Directors, charges & compliance details.
CIN U51909OR2022PTC039801 Incorporated 23 May 2022 ROC Cuttack HQ Ranpur, Odisha, India
Active Private Limited Company trading MSME · Micro
Data last updated
Revenue · FY 2026
₹5 Lakh
▼ 23% YoY
Net profit · FY 2026
₹14,827
Net margin 3%
EBITDA · FY 2026
₹49,319
EBITDA margin 9.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Define Pharmaceuticals Private Limited

Data last updated:

Define Pharmaceuticals Private Limited is a private limited company based in Ranpur, Odisha, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 23 May 2022.

The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51909OR2022PTC039801.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanyasi Pradhan (Managing Director) and Jyotirmayee Pati.

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Satyabhama Pradhan Beguniapatana Po Khatia Ps Sarankula, Ranpur, Odisha, India – 752079.

As per the financials filed for FY 2026, the company reported a revenue of ₹5 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹14,827 (net margin 3%) and EBITDA of ₹49,319 (EBITDA margin 9.9%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.

Define Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-24-0004145).

Company details

CIN U51909OR2022PTC039801
Registration Number 039801
Incorporation Date 23 May 2022
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-OD-24-0004145

Recognitions & Rankings of Define Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-OD-24-0004145

Contact details

Define Pharmaceuticals Private Limited's registered office is in Ranpur, Odisha.

  • Registered Address
    C/O Satyabhama Pradhan Beguniapatana Po Khatia Ps Sarankula, Ranpur, Odisha, India – 752079
  • Industry
    Trading, Specialty, Wholesale
Comprehensive company report
Define Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Define Pharmaceuticals Private Limited

FY 2025 filings available

Define Pharmaceuticals Private Limited reported revenue of ₹5 Lakh (down 23% YoY) for FY 2026.

Revenue · FY 2026
₹5 Lakh ▼ 23%
Net profit · FY 2026
₹14,827 margin 3%
EBITDA · FY 2026
₹49,319 margin 9.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 23%
3 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▼ 21%
3 years · compounded
▲ 35%

Revenue fell 23% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 19%. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹49,319
Profit Before Tax
Tax Expense
Net Profit (PAT)₹14,827
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin9.9%
Net Profit Margin3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Define Pharmaceuticals Private Limited, buy the company report.

Board of directors of Define Pharmaceuticals Private Limited

Define Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sanyasi PradhanManaging Director23 May 20224 Years 5 MonthsCurrent
Jyotirmayee PatiDirector23 May 20224 Years 5 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Define Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Define Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Define Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Jyotirmayee Pati was appointed as Director on 23 May 2022.

AGM
Define Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Define Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Cuttack.
Appointed
Jyotirmayee Pati was appointed as Director.
Appointed
Sanyasi Pradhan was appointed as Managing Director.
Incorporation
23 May 2022
Define Pharmaceuticals Private Limited was registered on 23 May 2022 with Roc Cuttack & aged 4 years 5 months as per MCA records.

Frequently asked questions

Define Pharmaceuticals is an active private limited company based in Ranpur, Odisha, India. The company works in specialty, within the trading industry. It was incorporated on 23 May 2022 (4+ years old) and is registered under CIN U51909OR2022PTC039801.

Define Pharmaceuticals has 2 current directors:

The latest financial statements of Define Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Define Pharmaceuticals is U51909OR2022PTC039801. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Define Pharmaceuticals was incorporated on 23 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Cuttack.

Jyotirmayee Pati was appointed as Director on 23 May 2022. Sanyasi Pradhan was appointed as Managing Director on 23 May 2022.

Yes, Define Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-24-0004145).

The registered office of Define Pharmaceuticals is at CO Satyabhama Pradhan Beguniapatana Po Khatia Ps Sarankula, Ranpur, Odisha, India – 752079.

Define Pharmaceuticals operates in the trading industry, in the specialty segment.

Define Pharmaceuticals can be reached at its registered office: CO Satyabhama Pradhan Beguniapatana Po Khatia Ps Sarankula, Ranpur, Odisha, India – 752079.